🔎 Trials Near Me

Akèy › Limfom Difize Gwo Selil B › Minnesota › Rochester

Etid klinik pou Limfom Difize Gwo Selil B nan Rochester, MN

10 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

Ap rekriteFaz 2
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06834373

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Ap rekriteFaz 1/2
  • Mayo Clinic Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05006716

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Ap rekriteFaz 2
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT03418038

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Ap rekriteFaz 1
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Ap rekriteFaz 1/2
  • Mayo Clinic, Clinical Trials Referral Office, Rochester
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Ap rekriteFaz 3
  • Mayo Clinic Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Ap rekriteFaz 2
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 26, 2024 · NCT06238648

Etid Limfom Difize Gwo Selil B nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.